Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Yu Li

Showing results (231-240 of 282) with videos related to

Pageof 29
Sort By:
Digestive Diseases and Sciences|July 12, 2011
Higher tacrolimus blood concentration is related to hyperlipidemia in living donor liver transplantation recipientsHong-Yu Li, Bo Li, Yong-Gang Wei, et al.
Archives of Pharmacal Research|June 20, 2019
Realgar transforming solution-induced differentiation of NB4 cell by the degradation of PML/RARα partially through the ubiquitin-proteasome pathwayYang Hai, Xin Wang, Peng Song, et al.
The Journal of Organic Chemistry|July 31, 2019
Diversity-Oriented Synthesis of Imidazo-Dipyridines with Anticancer Activity via the Groebke-Blackburn-Bienaymé and TBAB-Mediated Cascade Reaction in One PotYong Li, Jiu-Hong Huang, Juan-Li Wang, et al.
European Journal of Medicinal Chemistry|August 23, 2014
Synthesis and biological evaluation of hydroxycinnamic acid hydrazide derivatives as inducer of caspase-3Zheng-Rong Wu, Jian Liu, Jian-Ying Li, et al.
Journal of Medicinal Chemistry|April 17, 2020
Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent PolypharmacologyMarialuisa Moccia, Brendan Frett, Lingtian Zhang, et al.
Oncology Letters|March 29, 2021
NAMPT promotes hepatitis B virus replication and liver cancer cell proliferation through the regulation of aerobic glycolysisHui-Jie Guo, Hong-Yu Li, Zi-Hao Chen, et al.
Molecular Cancer Therapeutics|September 9, 2011
A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft modelsGenshi Zhao, Wei-Ying Li, Daohong Chen, et al.
Bioorganic & Medicinal Chemistry|June 21, 2018
Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cellsLiu-Jun He, Dong-Lin Yang, Shi-Qiang Li, et al.
European Journal of Medicinal Chemistry|May 21, 2025
Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitorPhuc Tran, Marialuisa Moccia, Xiuqi Wang, et al.
DNA and Cell Biology|October 21, 2011
Association between pri-miR-218 polymorphism and risk of hepatocellular carcinoma in a Han Chinese populationLu-Shun Zhang, Wei-Bo Liang, Lin-Bo Gao, et al.
Pageof 29

Showing results (231-240 of 282) with videos related to

Sort By:
Pageof 29
Digestive Diseases and Sciences|July 12, 2011
Higher tacrolimus blood concentration is related to hyperlipidemia in living donor liver transplantation recipientsHong-Yu Li, Bo Li, Yong-Gang Wei, et al.
Archives of Pharmacal Research|June 20, 2019
Realgar transforming solution-induced differentiation of NB4 cell by the degradation of PML/RARα partially through the ubiquitin-proteasome pathwayYang Hai, Xin Wang, Peng Song, et al.
The Journal of Organic Chemistry|July 31, 2019
Diversity-Oriented Synthesis of Imidazo-Dipyridines with Anticancer Activity via the Groebke-Blackburn-Bienaymé and TBAB-Mediated Cascade Reaction in One PotYong Li, Jiu-Hong Huang, Juan-Li Wang, et al.
European Journal of Medicinal Chemistry|August 23, 2014
Synthesis and biological evaluation of hydroxycinnamic acid hydrazide derivatives as inducer of caspase-3Zheng-Rong Wu, Jian Liu, Jian-Ying Li, et al.
Journal of Medicinal Chemistry|April 17, 2020
Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent PolypharmacologyMarialuisa Moccia, Brendan Frett, Lingtian Zhang, et al.
Oncology Letters|March 29, 2021
NAMPT promotes hepatitis B virus replication and liver cancer cell proliferation through the regulation of aerobic glycolysisHui-Jie Guo, Hong-Yu Li, Zi-Hao Chen, et al.
Molecular Cancer Therapeutics|September 9, 2011
A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft modelsGenshi Zhao, Wei-Ying Li, Daohong Chen, et al.
Bioorganic & Medicinal Chemistry|June 21, 2018
Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cellsLiu-Jun He, Dong-Lin Yang, Shi-Qiang Li, et al.
European Journal of Medicinal Chemistry|May 21, 2025
Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitorPhuc Tran, Marialuisa Moccia, Xiuqi Wang, et al.
DNA and Cell Biology|October 21, 2011
Association between pri-miR-218 polymorphism and risk of hepatocellular carcinoma in a Han Chinese populationLu-Shun Zhang, Wei-Bo Liang, Lin-Bo Gao, et al.
Pageof 29